Non-invasive radiogenomic mapping of the SMARCAL1-driven ferroptotic niche is associated with longitudinal MRD-negative surveillance in early-stage NSCLC - Summary - MDSpire

Non-invasive radiogenomic mapping of the SMARCAL1-driven ferroptotic niche is associated with longitudinal MRD-negative surveillance in early-stage NSCLC

  • By

  • Zehao Huang

  • JunDao He

  • Yue Li

  • ZhanYu Xu

  • Huajian Peng

  • Xiang Gao

  • HuaFu Zhou

  • JianJi Guo

  • Nuo Yang

  • May 25, 2026

  • 0 min

Share

Objective:

To investigate whether pre-operative radiomic features can non-invasively capture the spatial organization of a ferroptosis-enriched, immune-active tumor microenvironment associated with sustained post-operative MRD negativity in early-stage NSCLC.

Key Findings:
  • High Rad-Score patients had longer metastasis-free survival (MFS) with HR = 0.32, P < 0.001.
  • Rad-Score remained independent after adjustment for 13 clinical covariates (adjusted HR = 0.66, P = 0.022).
  • High Rad-Score tumors exhibited elevated tumor mutational burden (TMB) and enriched CD8+ T cells and M1 macrophages.
  • SMARCAL1 knockout conferred resistance to ferroptosis and attenuated CXCR3+ CD8+ T cell transmigration.
Interpretation:

Remove unsupported conclusions and interpretations.

Limitations:
  • Study conducted at a single center, which may limit generalizability.
  • Requires prospective validation.
Conclusion:

Revise to eliminate unsupported claims and reflect only the findings presented.

Original Source(s)

Related Content